Pilot randomized phase II study of celecoxib in oral premalignant lesions
VA Papadimitrakopoulou, WN William Jr… - Clinical Cancer …, 2008 - AACR
Abstract Purpose: Cyclooxygenase-2 (COX-2)–specific inhibition suppresses
carcinogenesis in preclinical models and is a promising strategy for preventing oral cancer …
carcinogenesis in preclinical models and is a promising strategy for preventing oral cancer …
[PDF][PDF] Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions
VA Papadimitrakopoulou, N William Jr, J Dannenberg… - academia.edu
Abstract Purpose: Cyclooxygenase-2 (COX-2)^ specific inhibition suppresses
carcinogenesis in preclinical models and is a promising strategy for preventing oral cancer …
carcinogenesis in preclinical models and is a promising strategy for preventing oral cancer …
[PDF][PDF] Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions
VA Papadimitrakopoulou, N William Jr, J Dannenberg… - scholar.archive.org
Abstract Purpose: Cyclooxygenase-2 (COX-2)^ specific inhibition suppresses
carcinogenesis in preclinical models and is a promising strategy for preventing oral cancer …
carcinogenesis in preclinical models and is a promising strategy for preventing oral cancer …
[PDF][PDF] Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions
VA Papadimitrakopoulou, N William Jr, J Dannenberg… - researchgate.net
Abstract Purpose: Cyclooxygenase-2 (COX-2)^ specific inhibition suppresses
carcinogenesis in preclinical models and is a promising strategy for preventing oral cancer …
carcinogenesis in preclinical models and is a promising strategy for preventing oral cancer …
[引用][C] Pilot randomized phase II study of celecoxib in oral premalignant lesions
VA PAPADIMITRAKOPOULOU - Clin Cancer Res, 2008 - cir.nii.ac.jp
Pilot randomized phase II study of celecoxib in oral premalignant lesions | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Pilot randomized phase II study of celecoxib in oral premalignant lesions
VA Papadimitrakopoulou, WN William… - Clinical Cancer …, 2008 - experts.umn.edu
Purpose: Cyclooxygenase-2 (COX-2)-specific inhibition suppresses carcinogenesis in
preclinical models and is a promising strategy for preventing oral cancer. In this pilot …
preclinical models and is a promising strategy for preventing oral cancer. In this pilot …
[引用][C] Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions
VA PAPADIMITRAKOPOULOU… - Clinical cancer …, 2008 - pascal-francis.inist.fr
Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pilot randomized phase II study of celecoxib in oral premalignant lesions
VA Papadimitrakopoulou… - … : an official journal …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose Cyclooxygenase-2 (COX-2)-specific inhibition suppresses carcinogenesis in
preclinical models and is a promising strategy for preventing oral cancer. In this pilot …
preclinical models and is a promising strategy for preventing oral cancer. In this pilot …
Pilot randomized phase II study of celecoxib in oral premalignant lesions.
VA Papadimitrakopoulou, WN William Jr… - … Cancer Research: an …, 2008 - europepmc.org
Purpose Cyclooxygenase-2 (COX-2)-specific inhibition suppresses carcinogenesis in
preclinical models and is a promising strategy for preventing oral cancer. In this pilot …
preclinical models and is a promising strategy for preventing oral cancer. In this pilot …
Pilot randomized phase II study of celecoxib in oral premalignant lesions
VA Papadimitrakopoulou… - Clinical Cancer …, 2008 - mdanderson.elsevierpure.com
Purpose: Cyclooxygenase-2 (COX-2)-specific inhibition suppresses carcinogenesis in
preclinical models and is a promising strategy for preventing oral cancer. In this pilot …
preclinical models and is a promising strategy for preventing oral cancer. In this pilot …